Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...

After becoming a patient himself following a recent cancer diagnosis, a local doctor said he wants to share his story to ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

The ACS estimates that 626,140 people in the U.S. will die from cancer in 2026, amounting to about 1,720 deaths per day. Lung ...